Data / Form D filings / Mellitus, LLC
Mellitus, LLC: Form D filings
Mellitus, LLC, a biotechnology company in Boston, MA, filed 12 Form D notices with the SEC between 2013 and 2023. The latest, on August 31, 2023, reports $90,000 sold of a $750,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CIC Boston, 16th Floor, 50 Milk Street, Boston, MA, 02109
- Phone
- (617) 834-2008
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1588301
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | New notice | $750,000 | $90,000 | $660,000 | 2 | Aug 21, 2023 | sec.gov |
| May 7, 2019 | New notice | $2,802,306 | $2,802,306 | 11 | Apr 23, 2019 | sec.gov | |
| Oct 2, 2018 | New notice | $1,675,000 | $1,675,000 | 6 | Sep 21, 2018 | sec.gov | |
| Aug 13, 2018 | New notice | $1,749,999 | $1,749,999 | 2 | Jul 30, 2018 | sec.gov | |
| May 3, 2018 | New notice | $5,593,558 | $5,593,558 | 39 | Apr 24, 2018 | sec.gov | |
| May 8, 2017 | Amendment | $2,500,000 | $2,066,516 | $433,484 | 26 | Feb 17, 2017 | sec.gov |
| Mar 2, 2017 | New notice | $1,000,000 | $912,091 | $87,909 | 20 | Feb 17, 2017 | sec.gov |
| May 24, 2016 | New notice | $1,000,000 | $992,883 | $7,117 | 25 | May 13, 2016 | sec.gov |
| Jan 4, 2016 | New notice | $50,000 | $50,000 | 3 | Dec 1, 2015 | sec.gov | |
| Sep 28, 2015 | New notice | $150,000 | $150,000 | 2 | Sep 15, 2015 | sec.gov | |
| Aug 20, 2015 | New notice | $558,934 | $558,934 | 13 | Aug 12, 2015 | sec.gov | |
| Oct 3, 2013 | New notice | $2,217,491 | $2,217,491 | 17 | Sep 18, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gail Page | Director | |
| Edwin Henrie, II | Director | |
| John Tagliamonte | Executive Officer, Director | |
| Jose Halperin | Director | |
| Michael Chorev | Director | |
| Christopher de Souza | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 28, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mellitus, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.